{"id":7522,"date":"2021-01-12T00:00:00","date_gmt":"2021-01-12T00:00:00","guid":{"rendered":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2021\/01\/12\/few-ob-gyns-can-prescribe-buprenorphine-for-opioid-use\/"},"modified":"2021-01-13T18:10:28","modified_gmt":"2021-01-13T18:10:28","slug":"few-ob-gyns-can-prescribe-buprenorphine-for-opioid-use","status":"publish","type":"post","link":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2021\/01\/12\/few-ob-gyns-can-prescribe-buprenorphine-for-opioid-use\/","title":{"rendered":"Few Ob-Gyns Can Prescribe Buprenorphine for Opioid Use"},"content":{"rendered":"<h3>\n<p>Obstetrician-gynecologists able to prescribe buprenorphine more likely located in the suburbs<\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>TUESDAY, Jan. 12, 2021 (HealthDay News) &#8212; Fewer than 2 percent of obstetrician-gynecologists who accept Medicaid are able to prescribe buprenorphine, according to a study published online Dec. 11 in <em>JAMA Network Open<\/em><em><\/em>.<\/p>\n<p>Max Jordan Nguemeni Tiako, from the Yale School of Medicine in New Haven, Connecticut, and colleagues assessed the prevalence and geographic distribution of U.S. obstetrician-gynecologists who can prescribe buprenorphine (called X-waivered) in 2019. Data from 31,211 obstetrician-gynecologists identified from the Centers for Medicare &#038; Medicaid Services Physician Compare data set were linked to the Drug Addiction Treatment Act buprenorphine-waived clinician list.<\/p>\n<p>The researchers found that only 560 of the identified obstetrician-gynecologists (1.8 percent) were X-waivered. The odds of being X-waivered were higher among obstetrician-gynecologists in counties with less than 5 percent uninsured residents (adjusted odds ratio [aOR], 1.59) compared with providers in counties with greater than 15 percent uninsured residents. Obstetrician-gynecologists in suburban counties (e.g., urban population of \u00e2\u0089\u00a520,000 and adjacent to a metropolitan area) were more likely to be X-waivered (aOR, 1.85) compared with those in metropolitan counties. Obstetrician-gynecologists in states with a neonatal abstinence syndrome (NAS) rate of \u00e2\u0089\u00a515 per 1,000 births also had higher odds of being X-waivered (aOR, 4.94) compared with states with an NAS rate of five per 1,000 births or less. X-waivers were more likely among obstetrician-gynecologists without hospital privileges (aOR, 1.32).<\/p>\n<p>&#8220;Results of this study suggest that an opportunity exists for obstetrician-gynecologists to contribute to expanding the workforce of clinicians who can prescribe buprenorphine to further address the opioid epidemic&#8217;s association with maternal and infant morbidity and mortality,&#8221; the authors write.<\/p>\n<p><a href=\"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2774073?resultClick=3\" rel=\"noopener noreferrer\" target=\"_blank\">Abstract\/Full Text<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2020 <a href=\"http:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Obstetrician-gynecologists able to prescribe buprenorphine more likely located in the suburbs<\/p>\n","protected":false},"author":4,"featured_media":7727,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[85],"tags":[452,114,485,103],"acf":[],"_links":{"self":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/7522"}],"collection":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/comments?post=7522"}],"version-history":[{"count":0,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/7522\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media\/7727"}],"wp:attachment":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media?parent=7522"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/categories?post=7522"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/tags?post=7522"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}